MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, REGN made $3,605,400K in revenue. $661,600K in net income. Net profit margin of 18.35%.

Income Overview

Revenue
$3,605,400K
Net Income
$661,600K
Net Profit Margin
18.35%
EPS
$6.75
Unit: Thousand (K) dollars
Revenue Breakdown
    • Collaboration Revenue
    • Eylea Net Product Sales
    • EYLEAHD
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
3,605,400 3,884,300 3,754,300 3,675,600
Research and development
1,543,500 1,626,100 1,475,000 1,421,700
Acquired in-process research and development
101,900 18,700 83,100 10,000
Selling, general, and administrative
647,700 775,000 657,800 634,200
Cost of goods sold, collaboration and contract manufacturing-Product
373,400 318,700 281,000 275,600
Cost of goods sold, collaboration and contract manufacturing-Collaborationand Contract Manufacturing
296,000 265,900 240,600 254,600
Other operating (income) expense, net
-0 10,000 0
Total expenses
2,962,500 3,004,400 2,727,500 2,596,100
Income from operations
642,900 879,900 1,026,800 1,079,500
Other income (expense), net
201,200 176,000 755,800 442,800
Interest expense
12,900 12,200 19,300 3,600
Total other income (expense)
188,300 163,800 736,500 439,200
Income before income taxes
831,200 1,043,700 1,763,300 1,518,700
Income tax expense
104,000 199,100 303,300 127,100
Net income
727,200 844,600 1,460,000 1,391,600
Unrealized (loss) gain on debt securities
-65,800 7,100 15,700 22,100
Gain (loss) on foreign currency translation
200 1,400 800 1,300
Comprehensive income
661,600 853,100 1,476,500 1,415,000
Basic EPS
6.99 8.283 14.09 13.24
Diluted EPS
6.75 7.943 13.62 12.81
Basic Average Shares
104,000,000 103,000,000 103,600,000 105,100,000
Diluted Average Shares
107,700,000 107,400,000 107,200,000 108,600,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Eylea Net ProductSales$473,100K (-35.72%↓ Y/Y)EYLEAHD$468,400K US$286,100K (48.62%↑ Y/Y)Non Us$152,100K (64.25%↑ Y/Y)EYLEAHDAnd EYLEA-US$941,500K LIBTAYONet Product Sales$438,200K (53.70%↑ Y/Y)Praluent Net ProductSales-US$66,600K (17.25%↑ Y/Y)Evkeeza-US$45,700K (47.90%↑ Y/Y)Other Products$31,300K Lynozyfic$11,200K Collaboration Revenue$1,899,700K (24.07%↑ Y/Y)Product$1,534,500K (8.40%↑ Y/Y)Product And ServiceOther$171,200K (109.04%↑ Y/Y)Revenues$3,605,400K (19.04%↑ Y/Y)Other income(expense), net$201,200K (-37.52%↓ Y/Y)Income from operations$642,900K (8.65%↑ Y/Y)Total other income(expense)$188,300K (-39.90%↓ Y/Y)Total expenses$2,962,500K (21.56%↑ Y/Y)Interest expense$12,900K (48.28%↑ Y/Y)Income before incometaxes$831,200K (-8.15%↓ Y/Y)Research and development$1,543,500K (16.28%↑ Y/Y)Selling, general, andadministrative$647,700K (2.32%↑ Y/Y)Cost of goods sold,collaboration and contract...$373,400K (40.64%↑ Y/Y)Cost of goods sold,collaboration and contract...$296,000K (48.89%↑ Y/Y)Acquired in-processresearch and development$101,900K (728.46%↑ Y/Y)Net income$727,200K (-10.08%↓ Y/Y)Gain (loss) onforeign currency...$200K (118.18%↑ Y/Y)Income tax expense$104,000K (8.00%↑ Y/Y)Comprehensive income$661,600K (-21.77%↓ Y/Y)Unrealized (loss) gain ondebt securities-$65,800K (-272.70%↓ Y/Y)

REGN_BIG copy-svg-svg-svg

REGENERON PHARMACEUTICALS, INC. (REGN)

REGN_BIG copy-svg-svg-svg

REGENERON PHARMACEUTICALS, INC. (REGN)